Class II recall: Shilpa Medicare Limited: PEMRYDI RTU (pemetrexed injection), 100 mg/10 mL (10 mg/mL), Single-dose vial,

The FDA has classified a recall of PEMRYDI RTU (pemetrexed injection), 100 mg/10 mL, single-dose vials, manufactured by Zydus Lifesciences and distributed by Amneal Pharmaceuticals, as a Class II recall. According to the recall notice, the firm received market complaints of green to dark green discoloration in certain vials, affecting NDC 70121-2453-1.

Most relevant for: patients with cancer receiving pemetrexed chemotherapy treatment

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.